08/30/2011 - A dozen pharmaceutical companies have paid doctors in the US nearly $150m so far this year, according to industry data that suggests an increase in these controversial marketing and support practices.
The figures highlight the extent of entertainment, travel, consulting, education and research support to doctors – payments that the industry says are ethical and enhance health outcomes, but which critics believe can influence prescribing practices.
Allan Coukell, head of the Pew Prescription Project, a drug safety watchdog, said: “We need the medical community to work with the industry on research, but the marketing model is problematic. The first step is transparency and we are not even there yet.”
Read the full article Pharma Groups Pay $150m to US Doctors on the Financial Times' Web site.